Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Sector Update: Healthcare Stocks Rise Premarket Monday

Sector Update: Healthcare Stocks Rise Premarket Monday

MT newswireMT newswire2026/11/09 13:17
09:17 AM EST, 11/09/2026 (MT Newswires) -- Healthcare stocks were rising premarket Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.9% and the iShares Biotechnology ETF (IBB) advancing by 1.3%. Novo Nordisk (NVO) shares were up more than 1% after the company said a post hoc review of its Phase 3 trial found Wegovy 2.4 mg outperformed placebo on liver tests in 106 adults with MASH and liver scarring who had a BMI below 27. Roivant Sciences (ROIV) stock was up more than 2% after the company reported a higher fiscal Q2 revenue. ImmunityBio (IBRX) shares were down more than 12% after the company posted a wider Q3 net loss.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12